Unknown

Dataset Information

0

Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness.


ABSTRACT: The synthetic double-stranded RNA poly(I:C) is commonly used as an adjuvant to boost CD8 T-cell function; however, polyinosinic:polycytidylic acid [poly(I:C)] can also suppress autoimmune disease. The mechanism by which a single adjuvant achieves two distinct immunoregulatory roles is unknown. Although it is clear that coadministration of poly(I:C) with antigen elicits strong adjuvant effects in mice, we found that poly(I:C) injection before antigen substantially reduced antigen-dependent CD8 T-cell responses. Notably, CD8 T cells sensitized in poly(I:C)-pretreated mice failed to fully up-regulate IL-33R (ST2), which led to impaired T-cell receptor-independent responses to IL-33. In contrast, nonsensitized effector CD8 T cells responded robustly to IL-33 using a two-signal cytokine mechanism. During an acute lung response to Staphylococcus aureus enterotoxin, peripheral injection of poly(I:C) manifested a suppressive process by inhibiting the differentiation of both antigen- and IL-33-responsive CD8 effectors systemically. These findings highlight that early exposure to double-stranded RNA reverses its role as an adjuvant and, importantly, prevents IL-33R up-regulation on CD8 effector T cells to dampen inflammation.

SUBMITTER: Ngoi SM 

PROVIDER: S-EPMC3387033 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness.

Ngoi Soo Mun SM   St Rose Marie-Clare MC   Menoret Antoine M AM   Smith Dirk E DE   Tovey Michael G MG   Adler Adam J AJ   Vella Anthony T AT  

Proceedings of the National Academy of Sciences of the United States of America 20120611 26


The synthetic double-stranded RNA poly(I:C) is commonly used as an adjuvant to boost CD8 T-cell function; however, polyinosinic:polycytidylic acid [poly(I:C)] can also suppress autoimmune disease. The mechanism by which a single adjuvant achieves two distinct immunoregulatory roles is unknown. Although it is clear that coadministration of poly(I:C) with antigen elicits strong adjuvant effects in mice, we found that poly(I:C) injection before antigen substantially reduced antigen-dependent CD8 T-  ...[more]

Similar Datasets

| S-EPMC3332117 | biostudies-literature
2015-09-30 | GSE72791 | GEO
| S-EPMC4946783 | biostudies-literature
| S-EPMC6306427 | biostudies-other
| S-EPMC6256032 | biostudies-literature
| S-EPMC154348 | biostudies-literature
| S-EPMC6751247 | biostudies-literature
| S-EPMC1765450 | biostudies-literature
| S-EPMC3088596 | biostudies-literature
| S-EPMC2950111 | biostudies-literature